Experts say Investors may be valuing AI companies too generously if health systems can’t justify the costs of these tools.
the resources and investment from PSG will help accelerate other things we want to do in terms of AI utilization for workflow optimization.” PSG has previously invested in health tech companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback